Humidified high flow air for children and young people with Cystic Fibrosis (CF): A pilot study

Not Applicable

Completed

• Conditions: Cystic Fibrosis; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12616000363482
• Lead Sponsor: Auckland District Health Board (contact Dr David McNamara)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-21
• Study Completion: 2018-08-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Children and young people aged 6 years to 25 years with a confirmed diagnosis of cystic fibrosis
- Mild or moderate disease
- The participant is in a stable period of well-being.

Exclusion Criteria

- FEV1 <= 30% predicted for height, age and gender
- Participant already requires respiratory support in sleep with oxygen, HHF, CPAP or VPAP.
- Participant under the care of the Lung Transplant team
- Exacerbation or symptoms of an exacerbation within the last 4 weeks
- Participant has additional complex diagnosis such as immune deficiency, cardiac disease or malignancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respiratory rate in sleep measured during limited channel polysomnography in the home.[Overnight during sleep on the 5th night of each treatment period.]